Ipd, SC, USA Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Ipd, SC, USA Pharmaceutical Import Records from India — 3 Products, $6.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Ipd, SC, USA — Pharmaceutical Importer Profile (2026) | 3 Products, $6.2M Trade | TransData Nexus

Ipd, SC, USA

Pharmaceutical Importer · United States · Antibiotics Focus · $6.2M Total Trade · DGFT Verified

Ipd, SC, USA is a pharmaceutical importer based in United States with a total trade value of $6.2M across 3 products in 3 therapeutic categories. Based on 125 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Ipd, SC, USA sources from 1 verified Indian supplier, with Encube Ethicals Private Limited accounting for 100.0% of imports.

Ipd, SC, USA — Import Portfolio & Supplier Network

Ipd, SC, USA import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Ipd, SC, USA?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Encube Ethicals Private Limited	$12.6M	432	100.0%

Ipd, SC, USA sources from 1 verified Indian supplier across 317 distinct formulations. The sourcing is highly concentrated — Encube Ethicals Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Ipd, SC, USA Import?

Formulation	Value	Ships
Diclofenac sodium topical gel 1% lami	$614.1K	13
Clindamycin phosphate topical lotion, 1%,60ML (batch no.4cw61,4cw62,4cw60,4cw63,4cw64,4cw58,4cw59 mfg. dt. mar 2024,exp.	$146.2K	3
Ketoconazole cream 2%, 60GM b.no.4bt02 to 4bt04, mfg date jan 2024 exp date	$127.4K	3
Clindamycin phosphate topical lotion, 1%,60ML batch no.4cw69 to 4cw73 mfg dt. apr 2024 exp dt. mar	$117.8K	3
Clobetasol propionate ointment 0.05 percentage 60GM (batch no.5bl16,5bl17,5bl11,5bl13,5bl14 mfg.dt. feb 25,exp.dt jan	$115.5K	3
Ketoconazole cream 2%, 60GM (batch no. 4bt17a, 4bt16 , 4bt15 mfg. dt.mar 2024, exp. dt. feb 2026 )	$107.5K	3
Clobetasol propionate ointment 0.05% 60GM batch no.3bl102, 3bl94,3bl95, 3bl96 mfg.dec 2023 exp. nov	$101.3K	3
Clobetasol propionate cream 0.05% 60g tube b.no.4bk16,4bk18,4bk19,4bk17 mfg dt.apr 2024 exp dt.mar	$101.0K	3
Ketoconazole cream 2%, 60GM ( batch no.	$100.0K	2
Clobetasol propionate ointment 0.05 percentage 30GM b.no.4bl89 ,4bl90,4bl87 mfgdate dec 2024 exp date nov	$100.0K	2
Clindamycin phosphate topical solution USP,1% 60ML batch no.4bh129 to 4bh133 mfgdt. dec 2024 exp dt. nov	$100.0K	2
Adapalene gel 0.3% 45g tube b.no.4dl14 4dl12 4dl13 mfg date dec 2024 exp date nov	$100.0K	2
Clindamycin phosphate topical solution USP,1% 60ML batch no.4bh135,4bh140,4bh137,4bh138,4bh136,4bh141,4bh134,4bh139	$100.0K	2
Ketoconazole cream 2%, 30GM batch no.4bt22 mfg.may 2024 exp. apr	$100.0K	2
Metronidazole topical vaginal gel 0.75%70 gms tube ( batch no.5ln11,5ln10,5ln12,5ln08,5ln09,mfg. dt.mar 2025, exp. dt	$100.0K	2

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Clindamycin	Antibiotics	$3.0M	61	3.4%	3
2	Ketoconazole	Antifungals	$3.0M	61	5.5%	2
3	Dapsone	Antimalarial & Antiparasitic	$91.4K	3	0.4%	14

Ipd, SC, USA imports 3 pharmaceutical products across 3 categories into United States totaling $6.2M.

Ipd, SC, USA — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

International Packaging and Distribution (IPD) is a pharmaceutical importer and buyer based in the United States, specializing in the procurement of finished pharmaceutical formulations from India. Headquartered at 1300 Altura Road, Fort Mill, South Carolina, IPD plays a pivotal role in the U.S. pharmaceutical supply chain by sourcing a diverse range of pharmaceutical products to meet domestic demand. The company's operations are characterized by a focus on quality assurance and regulatory compliance, ensuring that imported products adhere to U.S. standards.

IPD's strategic sourcing from India underscores its commitment to leveraging global manufacturing capabilities to provide cost-effective and high-quality pharmaceutical solutions. By importing finished formulations, IPD contributes to the availability of essential medications in the U.S. market, catering to various therapeutic needs. The company's role as an importer is integral to the distribution network, facilitating the entry of international pharmaceutical products into the U.S. healthcare system.

2Distribution Network

IPD's distribution network is centered around its facility in Fort Mill, South Carolina, which serves as the primary hub for receiving and processing pharmaceutical imports. The company's logistics capabilities are tailored to handle temperature-sensitive products, ensuring compliance with stringent storage and transportation requirements. Geographically, IPD's operations are focused within the United States, with a particular emphasis on serving the southeastern region. While the company imports products from India, its distribution activities are primarily domestic, aiming to meet the needs of U.S. healthcare providers and patients.

3Industry Role

In the U.S. pharmaceutical supply chain, IPD functions as a pharmaceutical importer and buyer, specializing in sourcing finished pharmaceutical formulations from India. The company's role is crucial in bridging the gap between international manufacturers and the U.S. market, ensuring the availability of a diverse range of pharmaceutical products. By focusing on finished formulations, IPD contributes to the efficiency of the supply chain, reducing the need for domestic manufacturing of certain products and facilitating quicker market entry.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Ipd, SC, USA

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

IPD's sourcing strategy exhibits a high degree of concentration, with a significant portion of its imports originating from a single supplier, Encube Ethicals Private Limited. This single-source dependency could pose risks related to supply chain disruptions, such as production delays or quality control issues. However, the consistent volume of shipments and the long-standing relationship between IPD and Encube Ethicals suggest a stable and reliable partnership. The strategic choice to concentrate sourcing from one supplier may also allow IPD to negotiate favorable terms and ensure product consistency.

2Supply Chain Resilience

The resilience of IPD's supply chain is closely tied to its relationship with Encube Ethicals Private Limited. The lack of backup suppliers indicates a potential vulnerability in the event of disruptions. However, Encube Ethicals' adherence to international quality standards, including WHO-GMP certification, enhances the reliability of the supply chain. The focus on finished pharmaceutical formulations and the established logistics routes from India to the U.S. further contribute to the supply chain's stability.

3Strategic Implications

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which sets forth requirements for drug approval, labeling, and manufacturing practices. The FDA's Center for Drug Evaluation and Research (CDER) is responsible for evaluating new drugs and ensuring their safety and efficacy. For Indian generics to enter the U.S. market, they must undergo the Abbreviated New Drug Application (ANDA) process, demonstrating bioequivalence to the reference listed drug.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in the U.S. are stringent, necessitating that foreign manufacturers register with the FDA and comply with Good Manufacturing Practice (GMP) standards. The FDA recognizes various GMP certifications, including those from the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S), provided they meet FDA standards. Indian exporters seeking to supply IPD must ensure their facilities are FDA-registered and adhere to these recognized GMP standards. Additionally, wholesale distribution authorization is required for entities involved in the distribution of pharmaceutical products within the U.S.

Ipd, SC, USA — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

IPD's focus on importing antibiotics, antifungals, and antimalarial & antiparasitic drugs aligns with the ongoing demand for these essential medications in the U.S. market. The therapeutic areas chosen reflect a strategic response to public health needs, addressing prevalent infections and diseases. The substantial import value of clindamycin and ketoconazole indicates a targeted approach to meet specific market demands, while the inclusion of dapsone suggests attention to niche therapeutic areas.

2Sourcing Profile

IPD's sourcing strategy emphasizes generic drug procurement, focusing on finished pharmaceutical formulations. The preference for sourcing from India is driven by the country's robust pharmaceutical manufacturing capabilities, cost-effectiveness, and adherence to international quality standards. This approach allows IPD to offer a diverse product portfolio while maintaining competitive pricing in the U.S. market.

3Market Positioning

Based on its product mix, IPD serves a broad segment of the U.S. pharmaceutical market, including retail pharmacies, hospitals, and government tenders. The company's imports of antibiotics and antifungals cater to both outpatient and inpatient needs, while the inclusion of antimalarial & antiparasitic drugs positions IPD to serve specialized healthcare providers and public health initiatives.

Seller's Guide — How to Become a Supplier to Ipd, SC, USA

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with IPD by offering alternative products or formulations that meet the company's quality and regulatory standards. Gaps in IPD's current sourcing may include specific dosage forms, strengths, or packaging configurations not currently imported. Indian exporters can explore these opportunities by aligning their offerings with IPD's product strategy and the therapeutic areas of focus.

2Requirements & Qualifications

Indian exporters seeking to supply IPD and the U.S. market must ensure their manufacturing facilities are FDA-registered and comply with recognized GMP standards, such as WHO-GMP or PIC/S certifications. Products must undergo necessary testing and meet FDA labeling requirements. Additionally, exporters should be prepared to navigate the FDA's regulatory processes, including the ANDA submission for generic drugs, to facilitate market entry.

3How to Approach

To establish a relationship with IPD, Indian exporters should initiate contact by providing detailed product information, including specifications, certifications, and compliance with FDA standards. Participating in relevant industry trade shows and forums can enhance visibility and facilitate networking opportunities. Developing a clear regulatory filing strategy, including understanding the ANDA process, is crucial for timely market entry. Setting realistic timelines for regulatory approvals and aligning with IPD's procurement cycles will enhance the potential for a successful partnership.

Frequently Asked Questions — Ipd, SC, USA

What products does Ipd, SC, USA import from India?

Ipd, SC, USA imports 3 pharmaceutical products across 3 categories. Top imports: Clindamycin ($3.0M), Ketoconazole ($3.0M), Dapsone ($91.4K).

Who supplies pharmaceuticals to Ipd, SC, USA from India?

Ipd, SC, USA sources from 1 verified Indian suppliers. The primary supplier is Encube Ethicals Private Limited (100.0% of imports, $12.6M).

What is Ipd, SC, USA's total pharmaceutical import value?

Ipd, SC, USA's total pharmaceutical import value from India is $6.2M, based on 125 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Ipd, SC, USA focus on?

Ipd, SC, USA imports across 3 categories. The largest: Antibiotics (49.3%), Antifungals (49.3%), Antimalarial & Antiparasitic (1.5%).

Get Full Ipd, SC, USA Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.